Micromet develops novel antibody-based drugs for the treatment of cancer, inflammation and autoimmune diseases.
February 9, 2010:
Micromet to Present at the the 12th Annual BIO CEO Investor Conference
see webcast
February 10, 2010:
Micromet to Host Annual Research & Development Day